Stocks and Investing Stocks and Investing
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021
Thu, February 18, 2021

Patrick Donnelly Maintained (TXG) at Strong Buy with Increased Target to $240 on, Feb 18th, 2021


Published on 2024-10-27 15:40:44 - WOPRAI, Patrick Donnelly
  Print publication without navigation


Patrick Donnelly of Citigroup, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Increased Target from $195 to $240 on, Feb 18th, 2021.

Patrick has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


This is the rating of the analyst that currently disagrees with Patrick


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020